1. • http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf . Accessed November 2010. This is a comprehensive guideline resource for the use of antiretroviral agents in HIV-infected patients.
2. Campanini A, Marani M, Mastroianni A, et al.: Human immunodeficiency virus infection: personal experience in changes in head and neck manifestation due to recent antiretroviral therapies. Acta Otorhinolaryngol Ital 2005, 25(1):30–5.
3. Badiee P, Alborzi A, Davarpanah MA, Shakiba E: Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients. Arch Iran Med 2010, 13(4):282–7.
4. Miller CS, Berger JR, Mootoor Y, et al.: High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol 2006, 44(7):2409–15.
5. Shetty K: Current role of thalidomide in HIV-positive patients with recurrent aphthous ulcerations. Gen Dent 2007, 55(6):537–42.